Foghorn Therapeutics Inc.

FHTX chart

Foghorn Therapeutics Inc. news

• FOGHORN THERAPEUTICS Q3 COLLABORATION REVENUE USD 83.5 MILLION

  Moomoo · Nov 9, 3:09 PM EST

• Foghorn Therapeutics Reports Q3 2026 Results: Revenue Hits $83.5

  GuruFocus · Nov 9, 9:36 AM EST

• Foghorn Therapeutics Inc. reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 9, 9:31 AM EST

• Foghorn Therapeutics Inc. (FHTX) Tops Q3 EPS by 105c

  StreetInsider · Nov 9, 8:26 AM EST

• FHTX: Foghorn Therapeutics Inc. filed SEC Form 8-K: Results of...

  Quantisnow · Nov 9, 8:25 AM EST

• Foghorn Therapeutics Inc. (FHTX) Q3 Earnings and Revenues Beat Estimates

  Yahoo Finance · Nov 9, 7:40 AM EST

• Foghorn Therapeutics Reports Third-Quarter Financial and Corporate Update

  TipRanks · Nov 9, 7:35 AM EST

• Foghorn Therapeutics Q3 collaboration revenue jumps on catch-up adjustment

  TradingView · Nov 9, 7:31 AM EST

• Foghorn Therapeutics posts Q3 net income of $58M on revenue surge

  StreetInsider · Nov 9, 7:30 AM EST

• Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update

  Yahoo Finance · Nov 9, 7:22 AM EST

• Form 8K Foghorn Therapeutics Inc For: 9 November By Investing.com

  Investing.com Canada · Nov 9, 7:14 AM EST

• A quarterly profit accompanies a planned roughly 40% workforce cut at Foghorn Therapeutics (FHTX).

  Stock Titan · Nov 9, 7:07 AM EST

Foghorn Therapeutics Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-09
• 8-K8-K2026-11-09
• 8-K8-K2026-10-01
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• 8-K8-K2026-06-24
• 10-Q10-Q2026-05-07
• 8-K8-K2026-05-07
• DEF 14ADEF 14A2026-04-30
• 8-K8-K2026-04-21
• 10-K10-K2026-03-11
• 8-K8-K2026-03-11

About Foghorn Therapeutics Inc.

Ticker

FHTX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Cambridge, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1822462

Frequently asked questions